Otros idiomas Navamedic ASA

Acciones

Mercado cerrado - Oslo Bors Otros sitios de cotización 16:45:00 08/05/2024			Varia. Cinco días.	Varia. 1 de enero.
33,4 ^NOK	0,00 %		+3,09 %	-8,99 %

06/05	Navamedic lanza un fármaco contra la disfunción eréctil en Suecia	MT
30/04	Navamedic ASA comunica los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI

Navamedic Rolls Out Erectile Dysfunction Drug in Sweden	06/05
Navamedic ASA: Broad launch for Eroxon® in Sweden today	06/05
Navamedic ASA: Annual Report 2023	30/04
Navamedic ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	30/04
Navamedic Q1 2024: Successful product launch and steady operational progress	30/04
Navamedic ASA: Invitation to 2024 1st quarter presentation	23/04
Disclosure in NAVAMEDIC ASA	21/03
Major shareholder disclosure in Navamedic ASA	18/03
Navamedic ASA - Mandatory notification of trade by primary insider	15/03
Navamedic ASA: Resolution to increase the share capital in connection with exercise of employee options	15/03
Navamedic welcomes new shareholders	13/03
Navamedic ASA - Notification of Major Holdings	13/03
Ingerø Reiten Investment Divests Navamedic Stake in NOK95 Million Deal	13/03
Navamedic ASA: Notification of major shareholding and mandatory notification of trade	12/03
Contemplated block sale of existing shares in Navamedic ASA	12/03
An unknown buyer acquired unknown minority stake in Navamedic ASA (OB:NAVA) from Ingerø Reiten Investment Company As for NOK 95 million.	12/03
Navamedic ASA: Mandatory notification of trade	22/02
Navamedic ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	15/02
Navamedic Q4 and full year 2023: A year marked by new records and transformative growth initiatives	15/02
Navamedic ASA: Invitation to 2023 4th quarter presentation	13/02

No hay resultados para esta búsqueda